Immunohistological localization and possible functions of adrenomedullin

Hypertension Research

Volumn 26, Issue SUPPL., 2003, Pages

  Marutsuka, Kousuke ^a   Hatakeyama, Kinta ^a   Sato, Yuichiro ^a   Yamashita, Atsushi ^a   Sumiyoshi, Akinobu ^a   Asada, Yujiro ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Adrenomedullin; Anticoagulation; Atherosclerosis; Immunohistochemical localization; Mucosal defense

Indexed keywords

ADRENOMEDULLIN; ANTITHROMBIN; PROADRENOMEDULLIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; UROKINASE;

ANTIBACTERIAL ACTIVITY; ATHEROSCLEROSIS; AUDITORY SYSTEM; BLOOD CLOTTING; BLOOD VESSEL; CARDIOVASCULAR SYSTEM; CELLULAR DISTRIBUTION; CIRCULATION; ENDOCRINE SYSTEM; ENDOTHELIUM CELL; ESCHERICHIA COLI; GASTROINTESTINAL GLAND; GASTROINTESTINAL MUCOSA; GENITAL SYSTEM; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; IMMUNOREACTIVITY; MACROPHAGE; MUCOSAL IMMUNITY; NONHUMAN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RESPIRATORY TRACT MUCOSA; REVIEW; TISSUE DISTRIBUTION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADRENOMEDULLIN; ANIMALS; CARDIOVASCULAR SYSTEM; ENDOCRINE SYSTEM; HUMANS; IMMUNOHISTOCHEMISTRY; PEPTIDES;

EID: 0037300215     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.S33     Document Type: Review

References (58)

1. Kitamura K, Kangawa K, Kawamoto M, et al: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
2. Kitamura K, Sakata J, Kangawa K, Kojima M, Matsuo H, Eto T: Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun 1993; 194: 720-725.
3. Ichiki Y, Kitamura K, Kangawa K, Kawamoto, M, Matsuo H, Eto T: Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett 1994; 338: 6-10.
4. Tomoda Y, Isumi Y, Katafuchi T, Minamino N: Regulation of adrenomedullin secretion from cultured cells. Peptides 2001; 22: 1783-1794.
5. Eto T: A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001; 22: 1693-1711.
6. Hinson JP, Kapas S, Smith DM: Adrenomedullin, a multi-functional regulatory peptide. Endocrine Rev 2000; 21: 138-167.
7. Nishio K, Akai Y, Murao Y, et al: Increased plasma concentrations of adrenomedullin correlate with relaxation of vascular tone in patients with septic shock. Crit Care Med 1997; 25: 953-957.
8. Wang P: Adrenomedullin in sepsis and septic shock. Shock 1998; 10: 383-384.
9. Matsui E, Kitamura K, Yoshida M, et al: Biosynthesis and secretion of adrenomedullin and proadrenomedullin N-terminal 20 peptide in a rat model of endotoxin shock. Hypertens Res 2001; 24: 543-549.
10. Kobayashi K, Kitamura K, Hirayama N, Date H, Koiwaya Y, Eto T: Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J 1996; 131: 676-680.
11. Washimine H, Asada Y, Kitamura K, et al: Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue. Histochem Cell Biol 1995; 103: 251-254.
12. Ohta H, Tsuji T, Asai S, et al: One-step direct assay for mature type adrenomedullin with monoclonal antibodies. Clin Chem 1999; 45: 244-251.
13. Asada Y, Hara S, Marutsuka K, et al: Novel distribution of adrenomedullin-immunoreactive cells in human tissues. Histochem Cell Biol 1999; 112: 185-191.
14. Cameron VA, Fleming AM: Novel sites of adrenomedullin gene expression in mouse and rat tissues. Endocrinology 1998; 139: 2253-2264.
15. Jougasaki M, Wei C-M, Heubleum DM, Sanderg AM, Burnett JC: Immunohistochemical localization of adrenomedullin in canine heart and aorta. Peptides 1995; 16: 773-775.
16. Jougasaki M, Rodcheffer R, Redfield M, et al: Cardiac secretion of adrenomedullin in human heart failure. J Clin Invest 1996; 97: 2370-2376.
17. Kato J, Kobayashi K, Etoh T, et al: Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 1996; 81: 180-183.
18. Jougasaki M, Wei C-M, McKinley L, Burnett JC: Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995; 92: 286-289.
19. Shimokubo T, Sakata J, Kitamura K, Kangawa K, Matsuo H, Eto T: Augmented adrenomedullin concentrations in right ventricle and plasma of experimental pulmonary hypertension. Life Sci 1995; 57: 1771-1779.
20. Shimokubo T, Sakata J, Kitamura K, Kangawa K, Matsuo H, Eto T: Adrenomedullin: changes in circulating and cardiac tissue concentration in Dahl-sensitive rats on a high-salt diet. Clin Exp Hypertens 1996; 18: 949-961.
21. Ishimitu N, Nishikimi T, Saito Y, et al: Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158-2161.
22. Kohno M, Hanehisa T, Kano H, et al: Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996; 27: 102-107.
23. Caron KM, Smithies O: Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc Natl Acad Sci USA 2001; 98: 615-619.
24. Shindo T, Kurihara Y, Nishimatsu H, et al: Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 2002; 104: 1964-1971.
25. Shimosawa T, Shibagaki Y, Ishibashi K, et al: Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation 2002; 105: 106-111.
26. Chun TH, Itoh H, Ogawa Y, et al: Shear stress augments expression of C-type natriuretic peptide and adrenomedullin. Hypertension 1997; 29:1296-1302.
27. Shinoki N, Kawasaki T, Minamino N, et al: Shear stress down-regulates gene transcription and production of adrenomedullin in human aortic endothelial cells. J Cell Biochem 1998; 71: 109-115.
28. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM: PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990; 111: 2149-2158.
29. Olson NE, Chao S, Lindner V, Reidy MA: Intimal smooth muscle cell proliferation after balloon catheter injury: the role of basic fibroblast growth factor. Am J Pathol 1992; 140: 1017-1023.
30. Ross R: The pathogenesis of atherosclerosis: perspective for the 1990s. Nature 1993; 362: 801-809.
31. Kohno M, Kano H, Horio T, Yokokawa K, Yasunari K, Takeda T: Inhibition of endothelin production by adrenomedullin in vascular smooth muscle cells. Hypertension 1995; 25: 1185-1190.
32. Kano H, Kohno M, Yasunari K, et al: Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 1996; 14: 209-213.
33. Horio T, Kohno M, Kano H, Yokokawa K, Horio T, Yoshikawa J: Adrenomedullin as a novel antimigration factor of vascular smooth muscle cells. Circ Res 1995; 77: 660-664.
34. Hatakeyama K, Marutsuka K, Sato Y, Yamashita A, Asada Y: Expression of adrenomedullin in arteriosclerotic lesions. Proc Jpn Soc Pathol 2002; 91: 233 (Abstract).
35. Nakayama M, Takahashi K, Murakami O, et al: Adrenomedullin in monocytes and macrophages: possible involvement of macrophage-derived adrenomedullin in atherogenesis. Clin Sci 1999; 97: 247-251.
36. Libby M, Geng YJ, Aikawa M, et al: Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996; 7: 330-335.
37. Kamoi H, Kanazawa H, Hirata K, Kurihara N, Yano Y, Otani S: Adrenomedullin inhibits the secretion of cytokine-induced neutrophil chemoattractant, a member of interleukin-8 family, from rat alveolar macrophages. Biochem Biophys Res Commun 1995; 211: 1031-1035.
38. Iwasaki H, Shichiri M, Marumo F, Hirata Y: Adrenomedullin stimulates proline-rich tyrosine kinase 2 in vascular smooth muscle cells. Endocrinology 2001; 142: 564-572.
39. Iwasaki H, Eguchi S, Shichiri M, Marumo F, Hirata Y: Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology 1998; 139: 3432-3441.
40. Shimizu K, Tanaka H, Sunamori M, Marumo F, Shichiri M: Adrenomedullin receptor antagonism by calcitonin gene-related peptide (8-37) inhibits carotid artery neointimal hyperplasia after balloon injury. Circ Res 1999; 85: 1199-1205.
41. Nemerson Y: Tissue factor and hemostasis. Blood 1988; 71: 1-8.
42. Asada Y, Marutsuka K, Hatakeyama K, et al: The role of tissue factor in the pathogenesis of thrombosis and atherosclerosis. J Atheroscl Thromb 1998; 4: 135-139.
43. Broze GJ: Tissue factor pathway inhibitor. Thromb Haemost 1995; 74: 90-93.
44. Sugano T, Tsuji H, Masuda H, et al: Adrenomedullin inhibits angiotensin II-induced expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Arterioscler Thromb Vasc Biol 2001; 21: 1078-1083.
45. Marutsuka K, Asada Y, Hatakeyama K, Yamashita A, Sumiyoshi A: Adrenomedullin modulates expression of tissue factor and tissue factor pathway inhibitor in cultured human aortic endothelial cells in vivo. Atherosclerosis 2000; 151: 20 (Abstract).
46. Marutsuka K, Hatakeyama K, Yamashita A, Sato Y, Sumiyoshi A, Asada Y: Adrenomedullin augments the release and production of tissue factor pathway inhibitor in human aortic endothelial cells. Cardiovas Res 2003; 57: 232-237.
47. Marutsuka K, Asada Y, Hatakeyama K, Yamashita Y, Sato Y, Sumiyoshi A: Effects of adrenomedullin on coagulation/fibrinolysis factors in cultured human aortic endothelial cells, in Second International Symposium on Adrenomedullin and PAMP, Miyazaki, Japan 2000, p40 (Abstract).
48. Zhao C, Wang I, Lehrer RI: Widespread expression of β-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996; 396: 319-322.
49. Ganz T, Weiss J: Antimicrobial peptides of phagocytes and epithelia. Semin Hematol 1997; 34: 343-354.
50. Marutsuka K, Nawa Y, Asada Y, et al: Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect. Exp Physiol 2001; 86: 543-545.
51. Allaker RP, Zihni C, Kapas S: An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol Med Microbiol 1999; 23: 289-293.
52. Ando K, Ito Y, Kumada M, Fujita T: Oxidative stress increases adrenomedullin mRNA levels in cultured rat vascular smooth muscle cells. Hypertens Res 1998; 21: 187-191.
53. Kitani M, Asada Y, Sakata J, Kitamura K, Sumiyoshi A, Eto T: Cell density of adrenomedullin-immunoreactive cells in the gastric endocrine cells decreases in antral atrophic gastritis. Histopathology 1999; 34: 134-139.
54. Kitano H, Takeda T, Suzuki M, et al: Presence of mRNA for vasoactive intestinal polypeptide (VIP) and its receptor in the rat inner ear. Hear Res 1998; 121: 109-111.
55. Suzuki M, Kitano H, Kitanishi T, et al: RT-PCR analysis of mRNA expression of natriuretic polypeptide family and their receptors in rat inner ear. Brain Res Mol Brain Res 1998; 55: 165-168.
56. Fujimura T, Furukawa H, Doi Y, Makishima K, Fujimoto S: Immunoreactivity of endothelins and endothelin receptor in the stria vascularis of the mouse cochlea. Hear Res 1999; 128: 135-146.
57. Tono T, Shimozono M, Kawano H, Asada Y, Kitamura K, Komune S: Expression and immunohistochemical localization of adrenomedullin in the mouse cochlea. ORL J Otorhinolaryngol Relat Spec 2002; 64: 169-172.
58. Quirk WS, Seidman MD, Laurikainen EA, Nuttall AL, Miller JM: Influence of calcitonin-gene related peptide on cochlear blood flow and electrophysiology. Am J Otol 1994; 15: 56-60.